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Abstract
Background: Chronic exposure to arsenic in drinking water is associated with increased risk of type 2 diabetes mellitus
(T2DM) but the underlying molecular mechanism remains unclear.
Objectives: This study evaluated the interaction between single nucleotide polymorphisms (SNPs) in genes associated with
diabetes and arsenic exposure in drinking water on the risk of developing T2DM.
Methods: In 2009–2011, we conducted a follow up study of 957 Bangladeshi adults who participated in a case-control study
of arsenic-induced skin lesions in 2001–2003. Logistic regression models were used to evaluate the association between 38
SNPs in 18 genes and risk of T2DM measured at follow up. T2DM was defined as having a blood hemoglobin A1C level
greater than or equal to 6.5% at follow-up. Arsenic exposure was characterized by drinking water samples collected from
participants’ tubewells. False discovery rates were applied in the analysis to control for multiple comparisons.
Results: Median arsenic levels in 2001–2003 were higher among diabetic participants compared with non-diabetic ones
(71.6 mg/L vs. 12.5 mg/L, p-value ,0.001). Three SNPs in ADAMTS9 were nominally associated with increased risk of T2DM
(rs17070905, Odds Ratio (OR) = 2.30, 95% confidence interval (CI) 1.17–4.50; rs17070967, OR = 2.02, 95%CI 1.00–4.06;
rs6766801, OR = 2.33, 95%CI 1.18–4.60), but these associations did not reach the statistical significance after adjusting for
multiple comparisons. A significant interaction between arsenic and NOTCH2 (rs699780) was observed which significantly
increased the risk of T2DM (p for interaction = 0.003; q-value = 0.021). Further restricted analysis among participants exposed
to water arsenic of less than 148 mg/L showed consistent results for interaction between the NOTCH2 variant and arsenic
exposure on T2DM (p for interaction = 0.048; q-value = 0.004).
Conclusions: These findings suggest that genetic variation in NOTCH2 increased susceptibility to T2DM among people
exposed to inorganic arsenic. Additionally, genetic variants in ADAMTS9 may increase the risk of T2DM.
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Introduction
The prevalence of diabetes is increasing globally. In 2000, the
prevalence of diabetes was 2.8% and is projected to reach 4.4% in
2030 [1]. In the United States, the prevalence of diabetes is
estimated to be 8.3% in 2010 [2]. Type 2 diabetes mellitus
(T2DM) is a complex disease with multiple contributing factors.
Environmental factors such as diet [3,4] , life style [5], and
cigarettes smoking [6] are positively associated with onset of
T2DM. Genetic components have also been shown to be
associated with T2DM [7]. With its increased prevalence and
the enormous number of cases, diabetes is now a major health
problem worldwide.
Over 140 million people worldwide are exposed to arsenic-
contaminated water with levels over the World Health Organi-
zation’s recommended guideline value of 10 mg/L [8]. Epidemi-
ologic studies show that chronic exposure to arsenic in drinking
water, a toxic environmental pollutant, is associated with
significant increased risk of T2DM [9–18]. In vitro studies that
explored the pathogenesis of arsenic-induced T2DM have
implicated the involvement of several biological processes,
including the protein kinase B (PKB/Akt) pathway [19,20],
calcium-dependent calpain-10 proteolysis of SNAP-25 [21,22],
cellular adaptive response of oxidative stress [23,24], inhibition of
glucose-dependent insulin secretion [25],and endoplasmic reticu-
lum stress [26]. However, the molecular genetic mechanisms
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underlying arsenic-induced T2DM remain incompletely under-
stood.
Hypothesis-generating approaches are useful tools for discover-
ing novel mechanisms for identifying risk factors for complex
diseases like T2DM. For example, genome wide association studies
have identified 27 genetic variants that are associated with T2DM
[7] that had not been observed in hypothesis-driven studies. This
evidence shows that hypothesis-generating approach is an
alternative approach to discover novel genetic factors associated
with T2DM.
Meta-analysis of T2DM with 141,000 participants has identified
27 loci that are associated with T2DM. It is possible that some of
these variants may contribute to arsenic-induced T2DM. In this
paper, we examined gene-environment interactions between single
nucleotide polymorphisms (SNPs) in susceptible genes of T2DM
and arsenic exposure in drinking water on risks of T2DM in a
Bangladesh population.
Materials and Methods
Study design and participants
This is a follow up study based on a case-control study
conducted in 2001–2003 that was designed to identify environ-
mental and genetic risk factors for arsenic-related skin lesions. The
original case-control study enrolled 900 individuals with skin
lesions and 900 individuals without skin lesions who lived in rural
areas of Bangladesh where arsenic contaminated groundwater is
commonly used for drinking water [27]. From 2009 to 2011, we
successfully re-contacted 1,542 of these participants and 957
individuals agreed to participate in this follow up study.
Questionnaires were used to collect information on medical
history, cigarette smoking, and other risk factors in both 2001–
2003 (baseline) and 2009–2011 (follow-up). At both time periods,
water arsenic exposures were measured. Hemoglobin A1C level
was only measured at follow-up.
Of the 957 individuals, seventeen did not have adequate
genomic DNA for genotyping and nineteen individuals who
reported a diagnosis of T2DM prior to 2001 were excluded.
Additionally, two individuals who did not provide information
regarding their diabetes status in 2009–2011 were also excluded.
Thus, 919 individuals were included in this analysis. This study
was approved by the Institutional Review Boards of Harvard
School of Public Health and Dhaka Community Hospital. All
participants provided written informed consent prior to participa-
tion in any study activity.
Arsenic Exposure in Drinking Water
Arsenic exposure assessment in this study has been described
previously [27,28]. Briefly, trained interviewers collected drinking
water samples from the tubewell which was identified as the
primary source of drinking water for each participant. Water
samples were preserved with nitric acid and then analyzed for
arsenic by inductively coupled plasma mass spectroscopy by
Environmental Laboratory Services North Syracuse, NY, USA
following the U.S. Environmental Protection Agency Method
200.8 (U.S. Environmental Protection Agency 1994). The limit of
detection was 1 mg As/L. Water samples below the limit of
detection were recorded as 0.5 mg/L.
Identification of Type 2 Diabetes Cases
Two milliliters of blood was collected from all participants at
follow-up by venipuncture into Fluoride/EDTA vacutainers.
These samples were analyzed for hemoglobin A1C within
24 hours by the Diabetes Center in Pabna, Bangladesh using the
NycoCard HbA1C system following the manufacturer’s instruc-
tions (NycoCard HbA1C, Axis-Shield, Norway). Individuals were
defined as having T2DM if hemoglobin A1C >=6.5% following the
recommendation of the International Expert Committee on
Diabetes [29,30].
Selection Criterion of Single Nucleotide Polymorphism
Thirty-eight (SNPs) with potential biological functions were
identified by searching the HapMap database (http://hapmap.
ncbi.nlm.nih.gov/) using the following criteria:1) SNPs must be
located in the 32 reported susceptible genes of T2DM discovered
by meta-analysis of the exiting genome-wide association study [7];
2) SNPs were selected based on the population of Gujarati Indians
in Houston; 3) SNPs must be located in the 59-Untranslated
Region (59-UTR), 39-Untranslated Region (39-UTR), or non-
synonymous; 4) the minor allele frequency must be equal or
greater than 5% in the Gujarati Indians in Houston population.
All SNPs included in the analysis have potential biological
function. Non-synonymous SNPs result in the change of amino
acid sequence that may influence tertiary structure of target
proteins. 59-UTR SNPs may affect the translational efficiency
through modulating the mRNA stability. 39-UTR SNPs may
change the mRNA stability because micro RNA can potentially
bind to this region and further affect the half-life of pre-mRNA.
Genotyping Procedure of Single Nucleotide
Polymorphism
Briefly, 30 mL of DNA was aliquotted into the 96 wells plates
with concentrations ranging from 5 to 20 ng/mL. Genotyping was
performed on 5–20 ng/mL of DNA using Sequenome MassAR-
RAY iPLEX (San Diego, CA) by the Partners HealthCare Center
for Personalized Genetic Medicine (Boston, MA.). SNPs that failed
in test of Hardy-Weinberg Equilibrium with p-values,0.001 were
excluded from the analysis. Ten percent of the samples were
randomly selected and analyzed in duplicate for quality control,
and rates of genotyping concordance were greater than 99%.
Statistical Analysis
Wilcoxon rank sum test with continuity correction for
continuous variables and Fisher’s exact test for categorized
variables were used to compare baseline characteristics between
individuals with and without T2DM. The odds ratio (OR), 95%
confidence interval (CI) and p-value were estimated by multiple
logistic regression. Additive genetic models assessed the association
between SNPs and risk of T2DM, as well as the interaction
between SNPs and arsenic in drinking water at baseline (2001–
2003) on the risk of T2DM. The covariates in the analyses were
based on the information obtained in 2001–2003 including age
(continuous), sex, body mass index (continuous), smoking status
(never, and past or current), status of skin lesion (present, absent),
and natural logarithm transformed water arsenic. Education and
marital status were not included in the final model because it did
not significantly change the point estimates.
Examination of the data shows nonlinear arsenic exposure effect
on T2DM. Hence, we modeled arsenic effects nonlinearly using
penalized splines when studying the effects of individual SNPs and
arsenic exposure on T2DM, adjusting for age, sex, body mass
index (BMI) (calculated as weight (kg)/height (m)2), skin lesion, and
smoking. We also performed gene-level analyses by applying
kernel machine regression [31] to assess the joint effects of the
SNPs in a gene on T2DM risk, where log arsenic was modeled
using polynomial regression methods with 3 degrees of freedom to
model its nonlinear effect.
Arsenic, NOTCH2, and Type 2 Diabetes
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We next studied the interactions between a SNP and arsenic on
T2DM risk. In view of the nonlinear arsenic effect, we modeled
log arsenic using piecewise linear regression with knots at 1, 3, 5
and calculate the cross-product terms of SNPs. Using the fitted
interaction model, we estimated the effect of arsenic on T2DM for
each SNP. The p-values for the interaction terms were calculated
using the likelihood ratio test.
The adjustments of multiple comparisons were controlled by
using false discovery rates (FDR) methods [32] that controls the
probability of false discovery at a level set by researchers. In this
study, we set the FDR that is less or equal than 5% (q-value less or
equal to 0.05) to minimize false positive findings. Thus, any two-
sided p-values ,0.05 were considered statistically significant.
Additional information regarding raw data, scatter plots, and
analyses on continuous manner of glycated hemoglobin A1C can
be found in supplementary (Table S1, S2, S3, and S4; Figure S1,
S2, and S3). All statistical analyses were performed in R version
2.13 [33].
Results
In total, 919 individuals who had adequate DNA for genotyping
and did not report having T2DM at baseline (2001–2003) were
included in this analysis. Based on levels of blood hemoglobin A1C
in 2009–2011, we identified 83 cases of T2DM yielding a crude
prevalence of 9.0%. Table 1 shows the comparison of baseline
characteristics among participants with and without T2DM.
Overall, participants with T2DM had higher BMI, were older,
and had greater exposure to arsenic contaminated drinking water
compared with participants without T2DM. The median levels of
arsenic in drinking water in participants with T2DM was 71.6 mg/
L compared to 12.5 mg/L for participants without T2DM (p-value
,0?001). Male participants with T2DM were also more likely to
be ever or current smokers (42.1% versus 28.1%, P=0.004). The
frequency of skin lesion status did not significantly differ between
participants with and without T2DM (57.4% versus 51.8%, p-
value = 0.35).
Table S1 showed the summary characteristics of the SNPs
genotyped in this population. The minor allele frequency of the 38
SNPs ranged from 5% to 45% indicating that these are common
variants in a Bangladeshi population. Of these SNPs, 9 SNPs are
non-synonymous, 2 SNPs occur in 59-UTR, and 27 in 39-UTR.
We observed that three SNPs (rs17070905, rs17070967, and
rs6768801), all located within the ADAMTS9 gene, were associated
with an increased risk of T2DM (Table 2). After adjusting for age,
sex, BMI, smoking status, skin lesion, and arsenic in drinking water
at baseline (2001–2003), the adjusted ORs were 2.30 (95% CI:
1.17–4.50, p-value = 0.015), 2.02 (95% CI: 1.00–4.06, p-val-
ue = 0.049), and 2.33 (95% CI: 1.18–4.60, p-value = 0.015) for
rs17070905, rs17070967, and rs6766801 respectively. While the
nominal p-values for these 3 SNPs were significant (p,0.05), they
were no longer significant after adjusting for multiple comparisons
using FDR (q-value . 0.05 for all SNPs). Furthermore, the overall
association of ADAMTS9 and risks of T2DM reached statistical
significance using kernel machine based multi-marker test (p-value
= 0.006), but was not statistically significant after adjusting for
multiple comparisons at the FDR 5% level (q-value = 0.066).
In order to assess the interaction between SNPs and water
arsenic on risk of T2DM, for each SNP, we modeled the effect of
arsenic exposure using piecewise linear regression in the interac-
tion model. In Table 3, rs1051055 (CDC123), rs699780
(NOTCH2), and rs2688 (TCF2) interacted with arsenic in drinking
water to significantly increase the risk of T2DM with p-values for
the SNP-arsenic interactions as 0.008, 0.003, and 0.003,
respectively. These gene-environment interactions remained
significant after controlling for multiple comparisons (rs1051055,
q-value = 0.033; rs699780, q-value = 0.021; rs2688, q-val-
ue = 0.021).
To investigate the robustness of interaction between SNPs and
water arsenic exposure, we repeated these models in a subset of
this population that was exposed to water arsenic below 148 mg/L
(the 75th of arsenic exposure from drinking water). In these
restricted analyses, only the interaction term for rs699780
(NOTCH2) remained statistical significance (p= 0.048). The
interaction terms for rs1051055 (p= 0.613) and rs2688
(p = 0.219) were not significant. Therefore, we only considered
rs699780 in NOTCH2 for further analyses.
To further understand how the rs699780 (NOTCH2) modified
the concentration-response relationship between arsenic exposure
and T2DM, we examined the nonlinear arsenic effects using
polynomial regression with 3 degrees of freedom and stratified
data into the two allele groups (TT vs. CT/CC) for rs699780
(NOTCH2), where C alleles were characterized as the minor allele
and T alleles were characterized as the major allele in this
population. Participants with at least one copy of C allele in
rs699780 (Figure 1B) had significantly higher risk of T2DM at any
given levels of arsenic exposure from drinking water (p for
interaction = 0.012) compared to participants without C allele
(Figure 1A). Additionally, the relationship between arsenic
exposure and T2DM among participants with at least a C allele
showed a non-monotonic increasing trend, whereas those who had
T allele had a simple linear relationship.
Discussion
Using a candidate gene approach, this study observed that SNPs
within NOTCH2 gene significantly increased susceptibility to
arsenic-induced T2DM where individuals who carried the C allele
were significantly more likely to be diagnosed with T2DM at
follow up compared to individuals with the T allele for any given
arsenic exposure. In addition, we found that one SNP (rs699780)
located in NOTCH2 with potential biological function significantly
interacted with arsenic in drinking water on the risks of T2DM.
Restricting the analysis among participants exposed to arsenic
Figure 1. Exposure-response relationship between arsenic in
drinking water and diabetes by NOTCH2 in Dhaka, Bangladesh,
2001–2011. Restricted analyses were performed among people
exposed to water arsenic below 148 mg/L adjusting for age, sex, BMI,
smoking, skin lesion, and arsenic in drinking water using cubic
polynomial models. P for interaction was 0.012. Sample sizes were
316 for TT carriers and 325 for TC/CC carriers of rs699780. The solid line
indicated the estimated odds ratio using lowest exposure levels of
water arsenic as the reference. Water arsenic was natural logarithm-
transformed.
doi:10.1371/journal.pone.0070792.g001
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concentration in the drinking water at lower levels (,148 mg/L)
showed that the interaction between this SNP and arsenic
exposure in the drinking water remained statistically significant,
suggesting that the interaction effects was not driven by highly
exposed individuals. Furthermore, the risk of T2DM was
significantly higher in individuals who carried C allele of
rs699780 which indicated that the genetic variant in NOTCH2
increased susceptibility to T2DM among people exposed to
arsenic. Furthermore, we identified 3 SNPs in the ADAMTS9 gene
that were nominally associated with the risks of T2DM in an
arsenic-exposed population in Bangladesh. These findings provid-
ed additional information thatADAMTS9, the T2DM susceptible
gene discovered in the Caucasian population [7], may play a role
in etiology of T2DM in the Bangladesh population.
The observation that genetic variants in NOTCH2 interact with
arsenic exposure to increase the risk of T2DM provides new
insights into the pathogenesis of arsenic-related diabetes. It is
known that chronic exposure to arsenic in drinking water is
associated with an increase of interleukin-6 (IL-6) expression in
circulating lymphocytes [34]. Additionally, animal evidence shows
that chronic exposure to arsenite decreases toll-like receptor (TLR)
signaling which controls the expression of tumor necrosis factor
alpha , a cytokine strongly associated with risks of T2DM [35].
While NOTCH2 is generally involved in development and cell fate
decision, there is increasing evidence that NOTCH2 signaling is
important also for immune functions [36]. In particular,
NOTCH2 signaling pathway has been shown to suppress the
TLR-induced IL-6 and tumor necrosis factor alphaexpression in
macrophages [37]. Taken together, NOTCH2 and arsenic
exposure may act through TLR signaling that regulates the innate
immune response to increase the risk of T2DM. As such, genetic
Table 1. Distribution of Demographic, Lifestyle, and Arsenic Exposure Variables by Diabetes Status (n = 919) in Dhaka, Bangladesh,
2001–2003 (Baseline).
Diabetes [n(%)]
Variablea No (n =836) Yes (n =83) p-valueb
Age, years Mean (SD) 33.46 (11.7) 39.8 (10.8) ,0.001
Median (IQR) 33.0 (18.0) 40.0 (14.0)
Sex Male 505 (60.4) 53 (63.9) 0.558
Female 331 (39.6) 30 (36.1)
Marital status Single 222 (26.6) 9 (10.8) 0.003
Married 598 (71.5) 71 (85.5)
Widowed or divorced 16 (1.9) 3 (3.6)
Education attainment, year 0–6 487 (58.3) 50 (60.2) 0.888
7–12 319 (38.2) 30 (36.1)
.12 29 (3.5) 3 (3.6)
BMI, kg/m2 ,24.9 728 (93.5) 59 (71.1) ,0.001
§25.0 54 (6.4) 24 (28.9)
Cigarette smoking (among male only) Never 599 (71.9) 48 (57.8) 0.004
Past or current 234 (28.1) 35 (42.1)
Skin lesion Yes 480 (57.4) 43 (51.8) 0.353
No 356 (42.6) 40 (48.2)
Arsenic in drinking water in baseline (2001–2003),
mg/L
Mean (SD) 141.9 (249.6) 207.2 (279.0) ,0.001
Median (IQR) 12.5 (125.5) 71.6 (269.8)
aSD and IQR denoted standard deviation and interquartile range, respectively.
bP-values from Fisher’s exact test for sex, marital status, education attainment, BMI, cigarette smoking, and skin lesion; or from Wilcoxon rank sum test with continuity
correction for age, and arsenic in drinking water. 1 participant was missing for education and 8 participants were missing for smoking status.
doi:10.1371/journal.pone.0070792.t001
Table 2. Associations between SNPs and risks of type 2 diabetes in Dhaka, Bangladesh, 2001–2011.
Marker Gene Adjusted Odds Ratioa 95% Confidence Interval p-valueb q-value
rs17070905 ADAMTS9 2.30 1.17–4.50 0.015 0.247
rs17070967 ADAMTS9 2.02 1.00–4.06 0.049 0.408
rs6766801 ADAMTS9 2.33 1.18–4.60 0.015 0.247
aModels were adjusted for age, sex, BMI, smoking, skin lesion, and arsenic in drinking water using penalized splines.
bP-value for overall effects of three markers in ADAMST9 was 0.006 (q-value = 0.066) using kernel machine regression adjusting for age, sex, BMI, smoking, skin lesion,
and arsenic in drinking water.
doi:10.1371/journal.pone.0070792.t002
Arsenic, NOTCH2, and Type 2 Diabetes
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variants within NOTCH2 would modify the arsenic-associated
diabetic risks.
The prevalence of diabetes in our study was 9% (Table 1) which
was close to the value in the U.S. (8.3%) in 2010 [2]. However, the
prevalence of obesity (BMI greater than 30.0) was merely 1.0% (9
out of 919 participants) in our follow up study compared to the
obesity status in U.S. where 35.7% of adults have a BMI greater
than 30 in 2009–2010 [38]. This pattern suggests that other
environmental factors may significantly contribute the unexpected
high prevalence of diabetes in our study. One of the possible
explanations may be the much higher arsenic exposure from
drinking water compared to the values in U.S. The median arsenic
exposure in our study is 15.1 mg/L whereas the value is only
around 2 mg/L in U.S. [39]. This evidence may indicate that
beyond the personal health status (e.g. BMI), environmental
factors such as arsenic exposure should be considered as an
important risk factors for diabetes in Bangladesh.
This study had several limitations that should be considered.
First, this is a novel finding that needs to be replicated in other
populations to confirm the significant interaction between
rs699780 and arsenic exposure on T2DM risks. Second,
rs699780 is a 39-UTR SNP located in NOTCH2, but there is no
current evidence that it is associated with mRNA expression of
NOTCH2 based on the gene expression profile database [40].
Thus, additional studies are needed to determine if this genetic
variant in NOTCH2 is associated with differential gene expression
that would further validate our finding. Third, the non-monoton-
ically increasing pattern for arsenic exposure and risks of T2DM
among C allele carriers of rs699780 may not adequately explain
the underlying exposure-response curve. However, the piece-wise
regression model assessing the dose-response relationship between
arsenic exposure and diabetic risks among the whole population
showed that the arsenic exposure in the second quartile (from 2.7
to 20.1 mg/L) was not statistically significant (p-value = 0.07),
suggesting that the decreasing trend within this arsenic exposure
range may be due to insufficient sample size, unmeasured
confounding, or non-differential exposure misclassifications that
drive the associations toward the null. Lastly, the diagnosis of
T2DM was solely based on hemoglobin A1C levels in follow-up
period (2009–2011) in this study. However, hemoglobin A1C
levels can be affected by hemolytic anemia and deficiency of
micronutrition including vitamin B12 and folate that have been
found in Bangladesh population [41–43]. Therefore, this study
may suffer the caveat of disease misclassifications that will result in
potential bias for the association of arsenic exposure with diabetes.
Our study also has several strengths. We utilized continuous
arsenic exposure in each participant’s primary source of drinking
water to assess gene-environment interaction on risks of T2DM.
This approach facilitates the understanding how the exposure-
response relationship was modified by genetic variants which
cannot be ascertained if arsenic exposure was dichotomized.
Second, we utilized a hypothesis- driven approach in selecting
candidate genes based on their relationship to increased T2DM
risk as reported by the DIAGRAM consortium. This consortium
combined data from 42,000 controls and 99,000 T2DM cases in
an unbiased genome-wide association study to identify novel
genetic variants associated with T2DM. Third, inclusions criteria
of each SNP in target genes were based on their potential
biological effects. Selecting SNPs with possible roles on altering the
gene expression or protein function was a more plausible approach
compared with inclusions of intronic or intergenic SNPs.
Conclusions
In summary, we discovered a significant interaction between a
39-UTR SNP in NOTCH2 and arsenic exposure from drinking
water that increased the risk of T2DM. This finding provides the
first human evidence that NOTCH2 may be a gene potentially
involved in arsenic-associated T2DM. We also observed that SNPs
located in ADAMTS9 were nominally associated with an increased
risk of T2DM. This finding is consistent with previous association
studies discovered in the Caucasian population. Overall, these
results indicate that some individuals may be more genetically
susceptible to arsenic-induced T2DM.
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Figure S1 Scatter plots with arsenic exposure in
drinking water versus glycated hemoglobin A1c levels
by NOTCH2 (rs699780) genotype. Restricted scatter plots
were based on people exposed to water arsenic below 148 mg/L.
Sample sizes were 316 for TT carriers and 325 for TC/CC
carriers of rs699780. Water arsenic was natural logarithm-
transformed.
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Figure S2 Scatter plots with arsenic exposure in
drinking water versus glycated hemoglobin A1c levels
by self-reported diabetes. Restricted scatter plots were based
on people exposed to water arsenic below 148 mg/L. Sample sizes
were 849 for participants without self-reported diabetes and 46 for
those with self-reported diabetes. Water arsenic was natural
logarithm-transformed.
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senic in drinking water and % change of hemoglobin A1c
levels by NOTCH2. Restricted analyses were performed among
people exposed to water arsenic below 148 mg/L adjusting for age,
sex, BMI, smoking, skin lesion, and arsenic in drinking water using
cubic polynomial models. P for interaction was 0.044. Sample sizes
were 315 for TT carriers and 324 for TC/CC carriers of
rs699780. The solid line indicated the estimated odds ratio using
lowest exposure levels of water arsenic as the reference. Water
arsenic was natural logarithm- transformed.
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tions: 5UTR, 59-untranslated region; 3UTR, 39-untranlated
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Table 3. Interaction between SNPs and arsenic in drinking
water on risk of type 2 diabetes in Dhaka, Bangladesh, 2001–
2011.
Marker Gene p-value for interactiona q-valueb
rs1051055 CDC123 0.008c 0.033
rs699780 NOTCH2 0.003c 0.021
rs2688 TCF2 0.003c 0.021
aModels were adjusted for age, sex, BMI, smoking, skin lesion, SNPs and arsenic
in drinking water using piece-wise regression models.
bQ-values were calculated using FDR method for p for interaction among whole
population.
cP for interactions were 0.613 for rs1051055 (CDC123), 0.048 for rs699780
(NOTCH2), and 0.219 for rs2688 (TCF2) among people exposed to water arsenic
less than 148 mg/L.
doi:10.1371/journal.pone.0070792.t003
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splines. b Q-values were 0.247 for rs17070905, 0.408 for
rs17070967, and 0.247 for rs6766801 using FDR method.
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were adjusted for age, sex, BMI, smoking, skin lesion, SNPs and
arsenic in drinking water using piece-wise regression models. b q-
values were calculated using FDR method for p for interaction
among whole population. c P for interactions were 0.613 for
rs1051055 (CDC123), 0.048 for rs699780 (NOTCH2), and 0.219
for rs2688 (TCF2) among people exposed to water arsenic less than
148 mg/L.
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hemoglobin A1c levels. a Models were adjusted for age, sex,
BMI, smoking, skin lesion, and arsenic in drinking water using
penalized splines. Change of glycated hemoglobin A1c levels were
based on 1 unit increase on log water arsenic. b Q-values were
0.374 for rs17070905, 0.486 for rs17070967, and 0.374 for
rs6766801 using FDR method.
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Table S5 Interaction between SNPs and arsenic in
drinking water on % of glycated hemoglobin A1c levels.
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models. b Q-values were calculated using FDR method for p for
interaction among whole population.
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